IRVINE, CA, and HERSTAL, BELGIUM ? April 1, 2020 ? MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today updated its 2020 reporting calendar, moving its Q1 business update forward to April 9th from April 21st.